The Economics of Vaccine Development

DARTMOUTH INNOVATIONS Accelerator for Cancer

Yolanda Sanchez, PhD, uses an automotive analogy to describe some types of cancer cells: They’re like cars with two gas pedals and no brakes. As a cancer researcher, she looks for ways to crash that out-of-control car without harming the normal cars around it.

“A lot of cancer drugs harm normal cells almost as much tumor cells,” says Sanchez, a professor of molecular and systems biology at the Geisel School of Medicine and associate director for basic sciences at Dartmouth’s and Dartmouth-Hitchcock’s Norris Cotton Cancer Center. “My lab focuses on finding drugs that can kill a tumor cell and not harm the person.” Scientists like Sanchez who study cancer share a common goal: to make life better for patients. Unfortunately, it takes about 20 years for a discovery to progress from the laboratory to the marketplace, and just 1% of promising ideas complete the journey successfully. The Dartmouth Innovations Accelerator for Cancer aims to change that.

“Cest, vit audio voleseque doluptibus intusdae. Ut qui blat qui cus il experum int autem iustium. Nam ipsam as conetur aliquib eribus, torum fugia nobis mil maximo berchit quaecat esciam”